影像学研究细胞角蛋白19(CK19)阳性肝细胞癌进展  

Imaging research progresses of cytokeratin 19(CK19)-positive hepatocellular carcinoma

作　　者：符天旭 罗是是[1] 王振平 FU Tianxu;LUO Shishi;WANG Zhenping(Department of Radiology,Hainan Affiliated Hospital of Hainan Medical University,Hainan General Hospital,Haikou 570311,China;Department of Radiology,Hainan Hospital,Guangdong Provincial Hospital of Chinese Medicine,Haikou 570203,China)

机构地区：[1]海南医科大学附属海南医院(海南省人民医院)放射科,海南海口570311 [2]广东省中医院海南医院放射科,海南海口570203

出　　处：《中国医学影像技术》2024年第10期1603-1606,共4页Chinese Journal of Medical Imaging Technology

基　　金：海南省自然科学基金高层次人才项目(821RC677);海南省临床医学中心建设项目资助。

摘　　要：肝细胞癌(HCC)细胞角蛋白19(CK19)阳性与其侵袭性强、患者预后不良相关;通过影像学方法无创、精准预测CK19表达对制定恰当治疗方案及改善预后至关重要。本文就影像学针对CK19阳性HCC相关研究进展展开综述。Cytokeratin 19(CK19)positivity in tumor cells of hepatocellular carcinoma(HCC)is associated with high aggressiveness and poor prognosis.Noninvasive and accurate imaging prediction of CK19 expression is essential for scheming appropriate treatments and improving prognosis.The progresses in imaging researches of CK19-positive HCC were reviewed in this article.

关 键 词：癌 肝细胞 角蛋白19 诊断显像 

分 类 号：R735.7[医药卫生—肿瘤] R445[医药卫生—临床医学]